Trustcore Financial Services, LLC United Therapeutics Corp Transaction History

Trustcore Financial Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$174.81 - $241.14 $8,740 - $12,057	-50 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$99.9 - $121.13 $999 - $1,211	-10 Reduced 16.67%	50 $5,000
Q1 2020 May 07, 2020	BUY	$79.39 - $115.35 $1,587 - $2,307	20 Added 50.0%	60 $6,000
Q4 2019 Jan 30, 2020	BUY	$78.31 - $95.34 $3,132 - $3,813	40 New	40 $4,000
Q3 2018 Nov 09, 2018	SELL	$113.81 - $129.46 $1,820 - $2,071	-16 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$101.14 - $118.31 $1,618 - $1,892	16 New	16 $2,000

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Trustcore Financial Services, LLC with notifications on news.